MOUNTAIN VIEW, Calif., Nov. 7, 2016 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that management is scheduled to present at the following investor conferences in New York City:
- The Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 17, 2016, at 8:00 am ET.
- The Piper Jaffray Healthcare Conference on Tuesday, November 29, 2016, at 11:50 a.m. ET.
Live audio webcasts of the presentations may be accessed on the Event Calendar of the Investors section of IRIDEX's website at www.iridex.com. Replays of the webcasts will be available shortly after the conclusion of the presentations and will be archived on the Company's website for 30 days.
About IRIDEX
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through both direct and independent sales forces and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit the Company's website at http://www.iridex.com.
Logo - http://photos.prnewswire.com/prnh/20141001/149809
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/iridex-to-present-at-upcoming-investor-conferences-300358611.html
SOURCE IRIDEX Corporation
Company Contact: Atabak Mokari, CFO and VP, Corporate Development, 650-940-4700; Investor Relations Contact: Matt Clawson, Pure Communications, 949-370-8500, matt@purecommunicationsinc.com
